Efficacy and safety of 177Lu-labeled prostate-specific membrane antigen radionuclide treatment in patients with diffuse bone marrow involvement: a multicenter retrospective study - Gafita, Andrei; Fendler, Wolfgang P.; Hui, Wang; Sandhu, Shahneen; Weber, Manuel; Esfandiari, Rouzbeh; Calais, Jeremie; Rauscher, Isabel; Rathke, Hendrik; Tauber, Robert; Delpassand, Ebrahim S.; Weber, Wolfgang A.; et al. (European urology, 2020)
Im Titel ist "177" in 177Lu-labeled hochgestellt